The cellulite treatment market is expected to grow at a CAGR of 9.2% during the forecast period 2024-2031
Get a free sample survey PDF: https://www.datamintelligence.com/download-sample/cellulite-treatment-market?sg
USA – Latest Industry News 2025:
✅ 05 Nov 2025 – Merz Aesthetics: FDA clearance of Ultherapy PRIME for new body areas (arms, abdomen) – expansion of a non-invasive skin tightening platform related to body/anti-cellulite treatment strategies.
✅ April 24, 2025 – Candela: introduced Vbeam Pro laser platform (announced at 2025 meetings) – new energy-based device widely promoted for dermatological and physical indications.
Europe – Latest Industry News 2025:
✅ January 24, 2025 – Allergan Aesthetics (AbbVie) unveiled its multimodal AA Signature program at IMCAS 2025 (Paris) – part of its European commercialization and treatment protocol activity that touches body/skin quality management used alongside cellulite treatments.
✅ 14 Aug 2024 → Rollout Apr 2025 – Candela announced new FDA/market platform launches (Vbeam Pro featured at 2025 meetings) with European trade show presence and product promotion across EMEA in 2025.
Buy now and get 30% OFF – (Earn 50% OFF on 2+ referrals): https://www.datamintelligence.com/buy-now-page?report=cellulite-treatment-market?sg
Geographic market share:
• North America holds a significant share of the global cellulite treatment market, primarily due to high consumer spending on cosmetic procedures and the presence of advanced dermatology and aesthetic centers. The United States dominates this region, due to the popularity of non-surgical treatments such as laser therapy, radiofrequency and acoustic wave therapy. The growing acceptance of body contouring among both men and women is further contributing to regional growth.
• Europe represents the second largest market, supported by well-established healthcare infrastructure and high demand for cosmetic procedures in countries such as Germany, France, Italy, and the United Kingdom. The region is also benefiting from an aging population looking for antiaging and skin tightening solutions. The increasing availability of FDA and CE approved cellulite reduction technologies is boosting adoption in medical spas and clinics.
Buying guides
1. Increasing aesthetic awareness: The growing influence of social media and changing beauty standards are encouraging consumers to invest in body contouring and skin smoothing procedures.
2. Technological Advances: The introduction of minimally invasive and non-invasive treatment options such as laser therapy, cryolipolysis and radiofrequency enhance the safety, comfort and effectiveness of treatment.
3. Growing medical spa industry: Expansion of medical spas and dermatology clinics offering combination treatments for cellulite reduction is boosting market penetration.
4. Increased female labor force participation: Higher disposable income among working women accelerates spending on beauty treatments.
Get the report customized according to your requirements: https://www.datamintelligence.com/customize/cellulite-treatment-market?sg
By Process
Non-invasive (the largest segment today)
• Market position: non-invasive procedures (radiofrequency, ultrasound, acoustic waves, laser, cryolipolysis-type body contouring additives) lead the revenue in most reports and represent the single largest share of current market value. Typical listed stocks are concentrated at around ~35-50% of the process mix.
Minimally invasive (potential for faster growth)
• Market position: smaller than non-invasive today, but often cited as the fastest growing interventional category as new targeted techniques and injectables enter/exit the market. Conservatively estimate ~25-35% process revenue across multiple market divisions.
Topical (supplements and creams, lower revenue per patient)
• Market position: topical treatments (creams, serums, OTC actives and cosmetics) represent a significant but smaller revenue segment – ~10-25% depending on whether reports include retail OTC sales alongside clinical procedures.
By type of cellulite
• Soft cellulite (market leader)
Share: most reports show soft cellulitis as the largest patient/tumor segment around ~45-52% of commercially treated cases (patients seeking treatment and procedure choice skew towards the soft type).
• Hard cellulite
Share: usually the second largest piece – ~25-35%. Treatments often lean towards more aggressive/minimally invasive options due to stability and tethering.
• Edema Cellulitis
Smaller commercial share ~10-20%. Management often combines lymphatic/medical approaches and procedures. Purchase per patient may vary.
Get 2 Days Free Trial + 50% OFF DataM@ Subscription https://www.datamintelligence.com/reports-subscription?sg
Key Market Players:
Key players are Merz Pharma GmbH & Co KgaA, Inceler Medikal Co Ltd, Candela Corporation, Cynosure, Cutera Inc, Zimmer Aesthetics, Cymedics GmbH & Co KG, Beijing Nubway S&T Co Ltd, Endo Aesthetics LLC.
• Merz Pharma GmbH & Co KGaA – Merz (Merz Aesthetics) is a long-established global aesthetic company with portfolios of injectables and devices (Cellfina historically for cellulite, as well as other aesthetic products). is an established brand in the physician-led aesthetic markets and a worthy top-tier competitor in procedures targeting cellulite/skin laxity.
• İnceler Medikal Co Ltd – Turkish manufacturer known for ESWT (shockwave) and energy based devices used in dermatology and orthopedics. Shockwave therapy is used by some clinics as a non-invasive option to improve cellulite/skin texture, so İnceler plays a niche/local device role rather than global premium market share.
• Candela Corporation – World leading laser/IPL device with body contouring and skin tightening products (eg VelaShape platforms historically). Strong distributor network and clinical adoption give Candela a significant share among device providers in non-invasive cellulite solutions.
• Cynosure – Primary OEM aesthetic device (SculpSure and other body contouring systems). SculpSure and related platforms are commonly used in clinics for fat reduction and skin contouring Cynosure as a leading provider of devices in the non-invasive segment.
• Cutera, Inc. – Offers a range of body contouring solutions (truSculpt family) and has clinical approval for temporary cellulite reduction / subcutaneous fat reduction. another major global device competitor in the non-invasive market segment.
Contact us –
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us –
DataM Intelligence is a market research and consulting firm providing end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage the leading trends, insights and developments of our brands to unleash fast and intelligent solutions for customers like you. We include a multitude of syndicated reports and custom reports with a robust methodology.
Our research database includes countless statistics and in-depth analysis on a wide range of 6300+ reports in 40+ sectors that create business solutions for more than 200+ companies in 50+ countries. meeting the core business research needs that influence the growth trajectory of our vast clientele.
This version was published on openPR.
